The Use of Oxytocin in Personality Disorders: Rationale and Current Status

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Treatment Options in Psychiatry

• Publication date

  2014-10-04

• Fields of study

  Psychology

• Identifiers
  DOI 10.1007/s40501-014-0026-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin and social cognition in affective and psychotic disorders.

  2015cited by this paper
• Oxytocin Modulation of Amygdala Functional Connectivity to Fearful Faces in Generalized Social Anxiety Disorder

  2015cited by this paper
• A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery.

  2014cited by this paper
• Impairments of Interpersonal Functioning: Empathy and Intimacy in Borderline Personality Disorder

  2014cited by this paper
• Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.

  2014cited by this paper
• Modulation of Resting-State Amygdala-Frontal Functional Connectivity by Oxytocin in Generalized Social Anxiety Disorder

  2014cited by this paper
• Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia

  2014cited by this paper
• Oxytocin, motivation and the role of dopamine.

  2014cited by this paper
• Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.

  2014cited by this paper
• Interpersonal functioning in borderline personality disorder: a systematic review of behavioral and laboratory-based assessments.

  2014cited by this paper
• Neurobiological correlates of social anxiety disorder: an update

  2014cited by this paper
• Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy

  2013cited by this paper
• Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

  2013cited by this paper
• Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder

  2013cited by this paper
• Effects of single dose intranasal oxytocin on social cognition in schizophrenia.

  2013cited by this paper
• Facial affect recognition and schizotypal personality characteristics

  2013cited by this paper
• Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice.

  2013cited by this paper
• Neurocognitive profiles of people with borderline personality disorder

  2013cited by this paper
• Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.

  2013cited by this paper
• Effects of intranasal oxytocin on pupil dilation indicate increased salience of socioaffective stimuli.

  2013cited by this paper
• Empathic accuracy and cognition in schizotypal personality disorder.

  2013cited by this paper
• Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls

  2013cited by this paper
• Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression.

  2013cited by this paper
• Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions.

  2013cited by this paper
• Improving social perception in schizophrenia: the role of oxytocin.

  2013cited by this paper
• Hint, Hint: Theory of Mind Performance in Schizotypal Individuals

  2013cited by this paper
• Social Cognition in Schizophrenia: From Social Stimuli Processing to Social Engagement

  2013cited by this paper
• Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma

  2013cited by this paper
• Theory of mind deficits in patients with mild symptoms of major depressive disorder.

  2013cited by this paper
• Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain.

  2013cited by this paper
• Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

  2012cited by this paper
• Pharmacological and Cognitive Remediation Approaches

  2012cited by this paper
• A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions.

  2012cited by this paper
• Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.

  2012cited by this paper
• Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies.

  2012cited by this paper
• Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders – 5

  2012cited by this paper
• Human neuroimaging of oxytocin and vasopressin in social cognition.

  2012cited by this paper
• Psychological therapies for people with borderline personality disorder.

  2012cited by this paper
• Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin.

  2012cited by this paper
• Erratum to “A critical review of the influence of oxytocin nasal spray on social cognition in humans: Evidence and future directions” [Horm. Behav. 61 (2012) 410–418]

  2012cited by this paper
• Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.

  2012cited by this paper
• Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.

  2012cited by this paper
• Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research.

  2012cited by this paper
• Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches.

  2012cited by this paper
• Theory of mind and emotion regulation difficulties in adolescents with borderline traits.

  2011cited by this paper
• Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.

  2011cited by this paper
• The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

  2011cited by this paper
• Emotion recognition and oxytocin in patients with schizophrenia

  2011cited by this paper
• Oxytocin can hinder trust and cooperation in borderline personality disorder.

  2011cited by this paper
• Differential Effectiveness of Antipsychotics in Borderline Personality Disorder: Meta-Analyses of Placebo-Controlled, Randomized Clinical Trials on Symptomatic Outcome Domains

  2011cited by this paper
• Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

  2011cited by this paper
• The Neuropeptide Oxytocin Facilitates Pro-Social Behavior and Prevents Social Avoidance in Rats and Mice

  2011cited by this paper
• Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome.

  2011cited by this paper
• Evidence-based pharmacotherapy for personality disorders.

  2011cited by this paper
• Neuronal correlates of altered empathy and social cognition in borderline personality disorder

  2011cited by this paper
• Theory of Mind and psychometric schizotypy.

  2011cited by this paper
• Abnormal modulation of amygdala activity in schizophrenia in response to direct- and averted-gaze threat-related facial expressions.

  2011cited by this paper
• Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia

  2011cited by this paper
• Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities.

  2011cited by this paper
• Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study.

  2011cited by this paper
• Social effects of oxytocin in humans: context and person matter.

  2011cited by this paper
• Theory of mind impairments in euthymic bipolar patients.

  2010cited by this paper
• The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

  2010cited by this paper
• The Social Cognition and Interaction Training (SCIT): an extension to individuals with schizotypal personality features.

  2010cited by this paper
• Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data.

  2010cited by this paper
• Effects of intranasal oxytocin on emotional face processing in women.

  2010cited by this paper
• Impaired theory of mind performance in patients with recurrent bipolar disorder: Moderating effect of cognitive load.

  2010cited by this paper
• Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials.

  2010cited by this paper
• Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder

  2010cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

  2010cited by this paper
• Are personality disorders associated with social welfare burden in the United States?

  2010cited by this paper
• Facial emotion perception in schizophrenia: a meta-analytic review.

  2010cited by this paper
• Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials

  2010cited by this paper
• The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans.

  2010cited by this paper
• A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.

  2009cited by this paper
• Deficits in Implicit Attention to Social Signals in Schizophrenia and High Risk Groups: Behavioural Evidence from a New Illusion

  2009cited by this paper
• Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict.

  2009cited by this paper
• Facial expression and face orientation processing in schizophrenia.

  2009cited by this paper
• Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities.

  2008cited by this paper
• The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond.

  2008cited by this paper
• Impact of prosocial neuropeptides on human brain function.

  2008cited by this paper
• Social cognition and neurocognition as independent domains in psychosis.

  2008cited by this paper
• Implicit and explicit processes in social cognition.

  2008cited by this paper
• Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

  2007cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders

  2007cited by this paper
• Recognition of Nonverbal Affect and Schizotypy

  2007cited by this paper
• Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?

  2007cited by this paper
• Comparison of brief dynamic and cognitive–behavioural therapies in avoidant personality disorder

  2006cited by this paper
• Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

  2006cited by this paper
• Deficit in theory of mind is a risk for relapse of major depression.

  2006cited by this paper
• The functional significance of social cognition in schizophrenia: a review.

  2006cited by this paper
• A pilot study of social cognition and interaction training (SCIT) for schizophrenia

  2005cited by this paper
• Understanding and sharing intentions: The origins of cultural cognition

  2005cited by this paper
• Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

  2005cited by this paper
• Emotion recognition, 'theory of mind,' and social behavior in schizophrenia.

  2005cited by this paper
• Deficiency of theory of mind in patients with remitted mood disorder.

  2004cited by this paper
• Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

  2004cited by this paper
• The pathophysiology of schizophrenia disorders: perspectives from the spectrum.

  2004cited by this paper
• Olfaction and social drive in schizophrenia.

  2003cited by this paper

• Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies

  2025cites this paper
• Oxytocin modulates the effective connectivity between the precuneus and the dorsolateral prefrontal cortex

  2019cites this paper
• A Neuroscience-Oriented Research Approach to Borderline Personality Disorder

  2018cites this paper
• Past, present, and future of genetic research in borderline personality disorder.

  2018cites this paper
• A Neuroscience-Oriented Research Approach to Borderline Personality Disorder.

  2018cites this paper
• Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.

  2015cites this paper
• Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.

  2015cites this paper